Axa’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-14,000
Closed -$251K 1396
2017
Q2
$251K Sell
14,000
-55,400
-80% -$1.04M ﹤0.01% 1172
2017
Q1
$1.39M Sell
69,400
-900
-1% -$21K 0.01% 857
2016
Q4
$1.76M Buy
70,300
+700
+1% +$16.5K 0.01% 786
2016
Q3
$1.63M Sell
69,600
-3,500
-5% -$82.2K 0.01% 811
2016
Q2
$1.46M Buy
73,100
+3,800
+5% +$70.9K 0.01% 807
2016
Q1
$1.17M Buy
69,300
+1,100
+2% +$22.5K 0.01% 841
2015
Q4
$1.51M Sell
68,200
-11,300
-14% -$235K 0.01% 833
2015
Q3
$1.35M Sell
79,500
-11,700
-13% -$182K 0.01% 853
2015
Q2
$1.25M Hold
91,200
0.01% 913
2015
Q1
$1.25M Sell
91,200
-3,000
-3% -$34.6K 0.01% 896
2014
Q4
$996K Buy
94,200
+21,900
+30% +$259K ﹤0.01% 956
2014
Q3
$904K Buy
72,300
+3,500
+5% +$48.8K ﹤0.01% 935
2014
Q2
$941K Hold
68,800
﹤0.01% 949
2014
Q1
$830K Buy
68,800
+33,041
+92% +$379K ﹤0.01% 965
2013
Q4
$439K Buy
35,759
+16,900
+90% +$198K ﹤0.01% 1091
2013
Q3
$192K Buy
18,859
+300
+2% +$2.81K ﹤0.01% 1147
2013
Q2
$167K Buy
+18,559
New +$187K ﹤0.01% 1124

Other funds holding OME

Axa's OME Position: Q3 2017 in Review

Axa sold out of Omega Protein (OME) in Q3 2017, closing a stake of 14,000 shares — an estimated $251K sold.

Axa first reported a position in OME in Q2 2013 and held it in 17 quarters. The position peaked at $1.76M in Q4 2016. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

  • Axa reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
  • Axa sold 14,000 Omega Protein shares in Q3 2017, an estimated $251K.
  • Axa first reported a position in Omega Protein in Q2 2013 and held it in 17 quarters.
  • Axa's Omega Protein position peaked at $1.76M in Q4 2016.
  • 122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.